Home › Funds › Royce & Associates › TRDA
Royce & Associates position in TRDA
ENTRADA THERAPEUTICS INC · Health Care
Latest position (Q2 2026)82.90K sh
Reported value held$610.16K
Portfolio Weight0.00%
First reportedQ2 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 223.25K | $1.50M | New |
| Q3 2025 | 345.51K | $2.00M | Add |
| Q4 2025 | 247.15K | $2.54M | Reduce |
| Q1 2026 | 120.84K | $1.53M | Reduce |
| Q2 2026 | 82.90K | $610.16K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TRDA
- BlackRock Inc 2.58M sh · $19.01M · Q2 2026
- Vanguard Group 1.63M sh · $16.78M · Q4 2025
- Wellington Management Group 954.42K sh · $7.02M · Q2 2026
- Millennium Management 763.96K sh · $5.62M · Q2 2026
- Geode Capital Management 717.43K sh · $5.28M · Q2 2026
- AQR Capital Management 699.54K sh · $5.15M · Q2 2026
- JPMorgan Chase & Co 496.46K sh · $3.83M · Q2 2026
- Citadel Advisors 394.32K sh · $2.90M · Q2 2026
- Northern Trust Corp 309.94K sh · $2.28M · Q2 2026
- Charles Schwab Investment Management 197.14K sh · $1.45M · Q2 2026
- Morgan Stanley 191.65K sh · $1.41M · Q2 2026
- Renaissance Technologies 191.00K sh · $1.41M · Q2 2026